
Telomir Pharmaceuticals, Inc. Common Stock (TELO) Stock Ticker
Market factors today
Unlock the full TELO picture
About Telomir Pharmaceuticals, Inc. Common Stock
Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, and also to assist in recovery post-chemotherapy. It achieves this by disrupting and inhibiting inflammatory pathways that are triggered by interleukin-17. Established in 2021, the company was initially known as Metallo Therapies Inc., officially adopting the name Telomir Pharmaceuticals, Inc. on October 10, 2022. The company's headquarters are located in Baltimore, Maryland.
TELO stock facts
| Ticker symbol | TELO |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $82.5M |
| CEO | Erez Aminov |
| Employees | 2 |
| Headquarters | Miami, FL, US |
| IPO date | 2024-02-09 |
| Website | telomirpharma.com |
What you can see for TELO on Tickr
Live TELO price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TELO report.
Rankings
FAQ
What is the ticker symbol for Telomir Pharmaceuticals, Inc. Common Stock?
The ticker symbol for Telomir Pharmaceuticals, Inc. Common Stock is TELO, listed on the NASDAQ Capital Market.
What is TELO?
Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such…